Non-Insulin Therapies for Diabetes-United States Market Status and Trend Report 2013-2023
Report Summary
Non-Insulin Therapies for Diabetes-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Non-Insulin Therapies for Diabetes industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Non-Insulin Therapies for Diabetes 2013-2017, and development forecast 2018-2023
Main market players of Non-Insulin Therapies for Diabetes in United States, with company and product introduction, position in the Non-Insulin Therapies for Diabetes market
Market status and development trend of Non-Insulin Therapies for Diabetes by types and applications
Cost and profit status of Non-Insulin Therapies for Diabetes, and marketing status
Market growth drivers and challenges
The report segments the United States Non-Insulin Therapies for Diabetes market as:
United States Non-Insulin Therapies for Diabetes Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Non-Insulin Therapies for Diabetes Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Alpha-glucosidase Inhibitors
Amylin Agonists
Biguanides
Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Glinides / Meglitinides
GLP-1 Analogs / GLP-1 Agonists
Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
Sulfonylureas
Thiazolidinediones
Others
United States Non-Insulin Therapies for Diabetes Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital Pharmacy
Retail Pharmacies
Online Pharmacy
Others
United States Non-Insulin Therapies for Diabetes Market: Players Segment Analysis (Company and Product introduction, Non-Insulin Therapies for Diabetes Sales Volume, Revenue, Price and Gross Margin):
GSK
Eli Lilly
Sumitomo Dainippon Pharma
Intarcia Therapeutics
Servier
Jiangsu Hansoh Pharmaceutical
Novo Nordisk
Emisphere
Uni-Bio Science Group
Takeda
3SBio
Merck
Dong-A Pharmaceutical
Luye Pharma Group
Eurofarma
Geropharm
Alkem Labs
SatRx
Pfizer
Jiangsu Hengrui Medicine
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Non-Insulin Therapies for Diabetes-United States Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Non-Insulin Therapies for Diabetes industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole United States and Regional Market Size of Non-Insulin Therapies for Diabetes 2013-2017, and development forecast 2018-2023
Main market players of Non-Insulin Therapies for Diabetes in United States, with company and product introduction, position in the Non-Insulin Therapies for Diabetes market
Market status and development trend of Non-Insulin Therapies for Diabetes by types and applications
Cost and profit status of Non-Insulin Therapies for Diabetes, and marketing status
Market growth drivers and challenges
The report segments the United States Non-Insulin Therapies for Diabetes market as:
United States Non-Insulin Therapies for Diabetes Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
New England
The Middle Atlantic
The Midwest
The West
The South
Southwest
United States Non-Insulin Therapies for Diabetes Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Alpha-glucosidase Inhibitors
Amylin Agonists
Biguanides
Dipeptidyl Peptidase-4 (DPP4) Inhibitors
Glinides / Meglitinides
GLP-1 Analogs / GLP-1 Agonists
Sodium-glucose Cotransporter 2 (SGLT2) Inhibitors
Sulfonylureas
Thiazolidinediones
Others
United States Non-Insulin Therapies for Diabetes Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital Pharmacy
Retail Pharmacies
Online Pharmacy
Others
United States Non-Insulin Therapies for Diabetes Market: Players Segment Analysis (Company and Product introduction, Non-Insulin Therapies for Diabetes Sales Volume, Revenue, Price and Gross Margin):
GSK
Eli Lilly
Sumitomo Dainippon Pharma
Intarcia Therapeutics
Servier
Jiangsu Hansoh Pharmaceutical
Novo Nordisk
Emisphere
Uni-Bio Science Group
Takeda
3SBio
Merck
Dong-A Pharmaceutical
Luye Pharma Group
Eurofarma
Geropharm
Alkem Labs
SatRx
Pfizer
Jiangsu Hengrui Medicine
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF ARTIFICIAL KNEE JOINT
1.1 Definition of Artificial Knee Joint in This Report
1.2 Commercial Types of Artificial Knee Joint
1.2.1 By Material
1.2.2 Stainless Steel
1.2.3 Cobalt-chromium Alloys
1.2.4 Titanium and Titanium Alloys
1.2.5 Polyethylene
1.2.6 Ceramics
1.2.7 Others
1.2.8 By Fixed Type
1.2.9 Bone Cement Type
1.2.10 Non-Bone Cement Type
1.3 Downstream Application of Artificial Knee Joint
1.3.1 Hospitals
1.3.2 Specialized Orthopedic Clinics
1.3.3 Ambulatory Surgical Centers
1.4 Development History of Artificial Knee Joint
1.5 Market Status and Trend of Artificial Knee Joint 2013-2023
1.5.1 Global Artificial Knee Joint Market Status and Trend 2013-2023
1.5.2 Regional Artificial Knee Joint Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Artificial Knee Joint 2013-2017
2.2 Production Market of Artificial Knee Joint by Regions
2.2.1 Production Volume of Artificial Knee Joint by Regions
2.2.2 Production Value of Artificial Knee Joint by Regions
2.3 Demand Market of Artificial Knee Joint by Regions
2.4 Production and Demand Status of Artificial Knee Joint by Regions
2.4.1 Production and Demand Status of Artificial Knee Joint by Regions 2013-2017
2.4.2 Import and Export Status of Artificial Knee Joint by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Artificial Knee Joint by Types
3.2 Production Value of Artificial Knee Joint by Types
3.3 Market Forecast of Artificial Knee Joint by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Artificial Knee Joint by Downstream Industry
4.2 Market Forecast of Artificial Knee Joint by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ARTIFICIAL KNEE JOINT
5.1 Global Economy Situation and Trend Overview
5.2 Artificial Knee Joint Downstream Industry Situation and Trend Overview
CHAPTER 6 ARTIFICIAL KNEE JOINT MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Artificial Knee Joint by Major Manufacturers
6.2 Production Value of Artificial Knee Joint by Major Manufacturers
6.3 Basic Information of Artificial Knee Joint by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Artificial Knee Joint Major Manufacturer
6.3.2 Employees and Revenue Level of Artificial Knee Joint Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ARTIFICIAL KNEE JOINT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 B. Braun
7.1.1 Company profile
7.1.2 Representative Artificial Knee Joint Product
7.1.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of B. Braun
7.2 Smith & Nephew
7.2.1 Company profile
7.2.2 Representative Artificial Knee Joint Product
7.2.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Smith & Nephew
7.3 Zimmer Biomet Holding Inc.
7.3.1 Company profile
7.3.2 Representative Artificial Knee Joint Product
7.3.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Zimmer Biomet Holding Inc.
7.4 Stryker
7.4.1 Company profile
7.4.2 Representative Artificial Knee Joint Product
7.4.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Stryker
7.5 Exactech
7.5.1 Company profile
7.5.2 Representative Artificial Knee Joint Product
7.5.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Exactech
7.6 Johnson & Johnson
7.6.1 Company profile
7.6.2 Representative Artificial Knee Joint Product
7.6.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.7 DJO Surgical
7.7.1 Company profile
7.7.2 Representative Artificial Knee Joint Product
7.7.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of DJO Surgical
7.8 Medtronic
7.8.1 Company profile
7.8.2 Representative Artificial Knee Joint Product
7.8.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Medtronic
7.9 Becton Dickinson
7.9.1 Company profile
7.9.2 Representative Artificial Knee Joint Product
7.9.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Becton Dickinson
7.10 Arthrex, Inc.
7.10.1 Company profile
7.10.2 Representative Artificial Knee Joint Product
7.10.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Arthrex, Inc.
7.11 ConforMIS
7.11.1 Company profile
7.11.2 Representative Artificial Knee Joint Product
7.11.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of ConforMIS
7.12 MicroPort Scientific Corporation
7.12.1 Company profile
7.12.2 Representative Artificial Knee Joint Product
7.12.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of MicroPort Scientific Corporation
7.13 OMNI life science
7.13.1 Company profile
7.13.2 Representative Artificial Knee Joint Product
7.13.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of OMNI life science
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ARTIFICIAL KNEE JOINT
8.1 Industry Chain of Artificial Knee Joint
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ARTIFICIAL KNEE JOINT
9.1 Cost Structure Analysis of Artificial Knee Joint
9.2 Raw Materials Cost Analysis of Artificial Knee Joint
9.3 Labor Cost Analysis of Artificial Knee Joint
9.4 Manufacturing Expenses Analysis of Artificial Knee Joint
CHAPTER 10 MARKETING STATUS ANALYSIS OF ARTIFICIAL KNEE JOINT
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Artificial Knee Joint in This Report
1.2 Commercial Types of Artificial Knee Joint
1.2.1 By Material
1.2.2 Stainless Steel
1.2.3 Cobalt-chromium Alloys
1.2.4 Titanium and Titanium Alloys
1.2.5 Polyethylene
1.2.6 Ceramics
1.2.7 Others
1.2.8 By Fixed Type
1.2.9 Bone Cement Type
1.2.10 Non-Bone Cement Type
1.3 Downstream Application of Artificial Knee Joint
1.3.1 Hospitals
1.3.2 Specialized Orthopedic Clinics
1.3.3 Ambulatory Surgical Centers
1.4 Development History of Artificial Knee Joint
1.5 Market Status and Trend of Artificial Knee Joint 2013-2023
1.5.1 Global Artificial Knee Joint Market Status and Trend 2013-2023
1.5.2 Regional Artificial Knee Joint Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of Artificial Knee Joint 2013-2017
2.2 Production Market of Artificial Knee Joint by Regions
2.2.1 Production Volume of Artificial Knee Joint by Regions
2.2.2 Production Value of Artificial Knee Joint by Regions
2.3 Demand Market of Artificial Knee Joint by Regions
2.4 Production and Demand Status of Artificial Knee Joint by Regions
2.4.1 Production and Demand Status of Artificial Knee Joint by Regions 2013-2017
2.4.2 Import and Export Status of Artificial Knee Joint by Regions 2013-2017
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Production Volume of Artificial Knee Joint by Types
3.2 Production Value of Artificial Knee Joint by Types
3.3 Market Forecast of Artificial Knee Joint by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Artificial Knee Joint by Downstream Industry
4.2 Market Forecast of Artificial Knee Joint by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF ARTIFICIAL KNEE JOINT
5.1 Global Economy Situation and Trend Overview
5.2 Artificial Knee Joint Downstream Industry Situation and Trend Overview
CHAPTER 6 ARTIFICIAL KNEE JOINT MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
6.1 Production Volume of Artificial Knee Joint by Major Manufacturers
6.2 Production Value of Artificial Knee Joint by Major Manufacturers
6.3 Basic Information of Artificial Knee Joint by Major Manufacturers
6.3.1 Headquarters Location and Established Time of Artificial Knee Joint Major Manufacturer
6.3.2 Employees and Revenue Level of Artificial Knee Joint Major Manufacturer
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 ARTIFICIAL KNEE JOINT MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 B. Braun
7.1.1 Company profile
7.1.2 Representative Artificial Knee Joint Product
7.1.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of B. Braun
7.2 Smith & Nephew
7.2.1 Company profile
7.2.2 Representative Artificial Knee Joint Product
7.2.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Smith & Nephew
7.3 Zimmer Biomet Holding Inc.
7.3.1 Company profile
7.3.2 Representative Artificial Knee Joint Product
7.3.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Zimmer Biomet Holding Inc.
7.4 Stryker
7.4.1 Company profile
7.4.2 Representative Artificial Knee Joint Product
7.4.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Stryker
7.5 Exactech
7.5.1 Company profile
7.5.2 Representative Artificial Knee Joint Product
7.5.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Exactech
7.6 Johnson & Johnson
7.6.1 Company profile
7.6.2 Representative Artificial Knee Joint Product
7.6.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.7 DJO Surgical
7.7.1 Company profile
7.7.2 Representative Artificial Knee Joint Product
7.7.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of DJO Surgical
7.8 Medtronic
7.8.1 Company profile
7.8.2 Representative Artificial Knee Joint Product
7.8.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Medtronic
7.9 Becton Dickinson
7.9.1 Company profile
7.9.2 Representative Artificial Knee Joint Product
7.9.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Becton Dickinson
7.10 Arthrex, Inc.
7.10.1 Company profile
7.10.2 Representative Artificial Knee Joint Product
7.10.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of Arthrex, Inc.
7.11 ConforMIS
7.11.1 Company profile
7.11.2 Representative Artificial Knee Joint Product
7.11.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of ConforMIS
7.12 MicroPort Scientific Corporation
7.12.1 Company profile
7.12.2 Representative Artificial Knee Joint Product
7.12.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of MicroPort Scientific Corporation
7.13 OMNI life science
7.13.1 Company profile
7.13.2 Representative Artificial Knee Joint Product
7.13.3 Artificial Knee Joint Sales, Revenue, Price and Gross Margin of OMNI life science
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF ARTIFICIAL KNEE JOINT
8.1 Industry Chain of Artificial Knee Joint
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF ARTIFICIAL KNEE JOINT
9.1 Cost Structure Analysis of Artificial Knee Joint
9.2 Raw Materials Cost Analysis of Artificial Knee Joint
9.3 Labor Cost Analysis of Artificial Knee Joint
9.4 Manufacturing Expenses Analysis of Artificial Knee Joint
CHAPTER 10 MARKETING STATUS ANALYSIS OF ARTIFICIAL KNEE JOINT
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
